Transparency in Payments

We engage ethically with all providers, and do so transparently and in compliance with country laws, regulations and trade association obligations.

We believe interactions with health care professionals and health care organizations bring value to patient care

AbbVie is committed to collaborating with health care professionals (HCPs), health care organizations (HCOs) and patient organizations to improve patient health across the globe.

Our interactions with HCPs, HCOs and patient organizations are guided by openness and transparency to ensure public trust and confidence. AbbVie supports disclosure of these relationships wherever possible to demonstrate the integrity of our relationships with HCPs, HCOs and patient organizations.

HCP/HCO disclosures inside the U.S.

Open payments—Physician Payments Sunshine Act

The US Sunshine Act, also known as the Open Payments—Physician Payments Sunshine Act, was enacted as federal law in 2010 as a component of the Affordable Care Act. The Act requires health care manufacturers, including AbbVie, to track financial transactions with certain health care providers (HCPs) and health care organizations (HCOs) and to disclose those transactions on an annual basis. We support the Act and its goal of providing the public greater visibility into interactions between the health care industry and HCPs to ensure public trust and confidence. To learn more,  view our FAQs.

U.S. Centers for Medicare and Medicaid Services (CMS) Open Payments Website

If you have questions on the data contained in the reports, please email [email protected].

Allergan acquisition

On May 8, 2020, AbbVie completed its acquisition of Allergan, which is now part of AbbVie.

To access Allergan’s payments and transfers of value submitted to CMS, please visit:

To access Allergan HCP / HCO disclosures outside of the U.S. please visit:

AbbVie HCP/HCO disclosures outside of the U.S.

Information exchanged with Healthcare Professionals (HCPs), Healthcare Organizations (HCOs) and patient organizations leads to newer and better therapies and, most importantly, enhanced care for patients. We believe interactions with healthcare professionals and healthcare organizations are essential to advance patient care, gain insights into unmet medical needs and progress the development of new medicines. Our interactions with HCPs and HCOs are based on trust, transparency and integrity, with a goal of providing the public with greater visibility into these interactions to ensure public trust and confidence. AbbVie engages in a range of activities from clinical research to sponsorships to educational activities to exchange information on how new medicines fit into the patient pathway. By bringing greater transparency to these relationships, AbbVie demonstrates its ongoing commitment to strengthening the basis for future collaboration.

European patient organization relationships

AbbVie is committed to making a remarkable impact on patients’ lives and their caregivers. We combine advanced science with a deep knowledge of the patient experience and healthcare systems to help people live better, more productive lives. We pursue learning about patient experiences to understand the issues, concerns and priorities of people affected by disease.

Patient organizations are a source of valuable information and support for patients and their caregivers. We foster patient organization relationships based on mutual trust, respect and goals that reflect AbbVie’s transparent and ethical behavioral standards. Through these relationships, AbbVie contributes to informing patients and caregivers about disease states, treatment options and how to improve quality of life. These partnerships facilitate dialogue between interested parties and help create new, cost-effective health care delivery models.

Annually, AbbVie publishes the financial support provided to European Patient Organizations. Our publication of the following country reports demonstrates our commitment to transparent disclosure of our financial relationships with patient organizations.

Bosnia and Herzegovina
Switzerland (GermanFrench)
United Kingdom

Additional Document

AbbVie’s 2021 European Patient Organization Report
AbbVie’s 2020 European Patient Organization Report

Serbia – Sponsored Professional Conferences

AbbVie has a long-standing commitment to supporting programs aimed at increasing the understanding of scientific, clinical and health care issues that improve patient care. In the interest of transparency, we are disclosing the following list of professional conferences sponsored by AbbVie.

Sponsored Professional Conferences 2013

Sponsored Professional Conferences 2014

Sponsored Professional Conferences 2015

Sponsored Professional Conferences 2016

Sponsored Professional Conferences 2017

Sponsored Professional Conferences 2018

Sponsored Professional Conferences 2019

Sponsored Professional Conferences 2020